No black box warning on record for Cuvrior

As of the latest FDA labeling reviewed, Cuvrior (TRIENTINE TETRAHYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cuvrior medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Potential for Worsening of Clinical Symptoms at Initiation of Therapy : May include neurological deterioration. Adjust dosage or discontinue CUVRIOR if clinical condition worsens. ( 5.1 ) Copper Deficiency : Periodic monitoring is required. ( 5.2 ) Iron Deficiency : If iron deficiency develops, a short course of iron supplementation may be given. ( 5.3 , 7.1 ) Hypersensi

No black box warning on record for Cuvrior

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Potential for Worsening of Clinical Symptoms at Initiation of Therapy : May include neurological deterioration. Adjust dosage or discontinue CUVRIOR if clinical condition worsens. ( 5.1 ) Copper Deficiency : Periodic monitoring is required. ( 5.2 ) Iron Deficiency : If iron deficiency develops, a short course of iron supplementation may be given. ( 5.3 , 7.1 ) Hypersensi

Cuvrior Black Box Warning

No black box warning on record for Cuvrior

Other warnings & precautions

Cuvrior Black Box Warning

No black box warning on record for Cuvrior

Other warnings & precautions